Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $14.07 billion. The enterprise value is $13.59 billion.
| Market Cap | 14.07B |
| Enterprise Value | 13.59B |
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 99.18 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 99.18M |
| Shares Outstanding | 99.18M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -1.46% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 101.77% |
| Float | 98.01M |
Valuation Ratios
The trailing PE ratio is 41.84 and the forward PE ratio is 16.75. NBIX's PEG ratio is 1.32.
| PE Ratio | 41.84 |
| Forward PE | 16.75 |
| PS Ratio | 5.65 |
| Forward PS | 4.48 |
| PB Ratio | 5.21 |
| P/TBV Ratio | 5.30 |
| P/FCF Ratio | 26.61 |
| P/OCF Ratio | 24.80 |
| PEG Ratio | 1.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.75, with an EV/FCF ratio of 25.70.
| EV / Earnings | 39.00 |
| EV / Sales | 5.41 |
| EV / EBITDA | 25.75 |
| EV / EBIT | 27.22 |
| EV / FCF | 25.70 |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.20 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | 0.93 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.39% and return on invested capital (ROIC) is 10.42%.
| Return on Equity (ROE) | 13.39% |
| Return on Assets (ROA) | 8.67% |
| Return on Invested Capital (ROIC) | 10.42% |
| Return on Capital Employed (ROCE) | 14.93% |
| Revenue Per Employee | $1.39M |
| Profits Per Employee | $193,500 |
| Employee Count | 1,800 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 18.63 |
Taxes
In the past 12 months, NBIX has paid $178.80 million in taxes.
| Income Tax | 178.80M |
| Effective Tax Rate | 33.92% |
Stock Price Statistics
The stock price has increased by +16.82% in the last 52 weeks. The beta is 0.28, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +16.82% |
| 50-Day Moving Average | 133.92 |
| 200-Day Moving Average | 125.37 |
| Relative Strength Index (RSI) | 58.78 |
| Average Volume (20 Days) | 726,338 |
Short Selling Information
The latest short interest is 4.13 million, so 4.17% of the outstanding shares have been sold short.
| Short Interest | 4.13M |
| Short Previous Month | 3.98M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 4.22% |
| Short Ratio (days to cover) | 4.34 |
Income Statement
In the last 12 months, NBIX had revenue of $2.51 billion and earned $348.30 million in profits. Earnings per share was $3.39.
| Revenue | 2.51B |
| Gross Profit | 1.58B |
| Operating Income | 499.10M |
| Pretax Income | 446.90M |
| Net Income | 348.30M |
| EBITDA | 527.60M |
| EBIT | 499.10M |
| Earnings Per Share (EPS) | $3.39 |
Balance Sheet
The company has $975.60 million in cash and $489.80 million in debt, giving a net cash position of $485.80 million or $4.90 per share.
| Cash & Cash Equivalents | 975.60M |
| Total Debt | 489.80M |
| Net Cash | 485.80M |
| Net Cash Per Share | $4.90 |
| Equity (Book Value) | 2.69B |
| Book Value Per Share | 27.22 |
| Working Capital | 1.20B |
Cash Flow
In the last 12 months, operating cash flow was $567.30 million and capital expenditures -$38.60 million, giving a free cash flow of $528.70 million.
| Operating Cash Flow | 567.30M |
| Capital Expenditures | -38.60M |
| Free Cash Flow | 528.70M |
| FCF Per Share | $5.33 |
Margins
Gross margin is 63.11%, with operating and profit margins of 19.89% and 13.88%.
| Gross Margin | 63.11% |
| Operating Margin | 19.89% |
| Pretax Margin | 21.00% |
| Profit Margin | 13.88% |
| EBITDA Margin | 21.02% |
| EBIT Margin | 19.89% |
| FCF Margin | 21.06% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 2.48% |
| FCF Yield | 3.76% |
Analyst Forecast
The average price target for NBIX is $161.50, which is 13.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $161.50 |
| Price Target Difference | 13.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 12.61% |
| EPS Growth Forecast (5Y) | 36.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 7.8 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.8 |
| Piotroski F-Score | 4 |